Related Experiment Video
Updated: May 17, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial fibrillation and atrial flutter: nonpharmacologic therapy
David L Johnson1, John D Day, John R Doty
1Intermountain Heart Institute, Department of Cardiology, Intermountain Medical Center, Murray, UT, USA.
Clinics in Geriatric Medicine
|October 30, 2012
Summary
Nonpharmacologic treatments for atrial fibrillation (AF) are crucial for elderly patients. Catheter ablation and minimally invasive surgery show promise for rhythm control in older adults, though more research is needed.
Area of Science:
- Cardiology
- Geriatrics
Background:
- Elderly patients with atrial fibrillation (AF) pose challenges for long-term medication management.
- Nonpharmacologic treatments offer a vital alternative for improving quality of life and function in older adults with AF.
Purpose of the Study:
- To review nonpharmacologic approaches for managing atrial fibrillation (AF) specifically in elderly patients.
- To evaluate the efficacy and safety of current nonpharmacologic interventions for AF in geriatrics.
Main Methods:
- Review of observational studies on catheter ablation in elderly versus younger patients.
- Analysis of data on minimally invasive surgical approaches for AF in specific elderly populations.
Main Results:
- Observational studies indicate comparable long-term efficacy and safety of catheter ablation in elderly and younger individuals.
- Minimally invasive surgical techniques present unique benefits for certain elderly patient groups.
Conclusions:
- Nonpharmacologic rhythm control strategies are important for elderly patients with AF.
- Further large-scale research is required to validate findings on age-related differences in nonpharmacologic AF treatments.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...